0001145549-22-061869.txt : 20221013 0001145549-22-061869.hdr.sgml : 20221013 20221013165027 ACCESSION NUMBER: 0001145549-22-061869 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220731 FILED AS OF DATE: 20221013 DATE AS OF CHANGE: 20221013 EFFECTIVENESS DATE: 20221013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Managed Portfolio Series CENTRAL INDEX KEY: 0001511699 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-22525 FILM NUMBER: 221309465 BUSINESS ADDRESS: STREET 1: 615 EAST MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 414-287-3700 MAIL ADDRESS: STREET 1: 615 EAST MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 0001511699 S000041846 Coho Relative Value Equity Fund C000129910 Institutional Class Shares COHIX C000129911 Coho Relative Value Equity Fund COHOX 0001511699 S000067007 Coho Relative Value ESG Fund C000215633 Coho Relative Value ESG Fund CESGX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001511699 XXXXXXXX true false false N-1A S000041846 true S000067007 true Managed Portfolio Series 811-22525 0001511699 254900SQ3GG01NP4WM65 615 East Michigan Street Milwaukee 53202 US-WI US 4147656844 U.S. Bancorp Fund Services, LLC 615 E. Michigan St. Milwaukee 53202 18336121912 Transfer agency, fund accounting and fund administration data U.S. Bank National Association 1555 N. Rivercenter Drive Suite 302 Milwaukee 53212 18336121912 Custody data Quasar Distributors, LLC 111 East Kilbourn Avenue Suite 2200 Milwaukee 53202 12075537110 Distribution data Foreside Fund Services, LLC Three Canal Plaza Suite 100 Portland 04101 12075537110 Distribution Data Compass Distributors, LLC Three Canal Plaza Suite 100 Portland 04101 12075537110 Distribution data Toroso Investments LLC 898 North Broadway Suite 2 Massapequa 11758 18449867676 Adviser data Coho Partners, Ltd. 300 Berwyn Park 801 Cassatt Road, Suite 100 Berwyn 19312 18662646234 Adviser data Cove Street Capital, LLC 2101 E. El Segundo Boulevard Suite 302 El Segundo 90245 18664970097 Adviser data Great Lakes Advisors, LLC 231 S. LaSalle Street 4th Floor Chicago 60604 18552782020 Adviser data Principal Street Partners, LLC 6075 Poplar Avenue Suite 221 Memphis 38119 18779147343 Adviser data Jackson Square Partners, LLC One Letterman Drive Building A, Suite A3-200 San Francisco 94129 18445773863 Adviser data Lawson Kroeker Investment Management, Inc. 450 Regency Parkway Suite 410 Omaha 68114 18556981378 Adviser data Muhlenkamp & Company, Inc. 5000 Stonewood Drive Suite 300 Wexford 15090 18008603863 Adviser data Nuance Investments LLC 4900 Main Street Suite 220 Kansas City 64112 18556826233 Adviser data Olstein Capital Management, L.P. 4 Manhattanville Road Purchase 10577 18007992113 Adviser data Port Street Investments, LLC 24 Corporate Plaza Suite 150 Newport Beach 92660 18553696220 Adviser data Saratoga Research & Investment Management 14471 Big Basin Way Suite E Saratoga 95070 18553696220 Adviser data Reinhart Partners, Inc. 1500 W. Market Street Suite 100 Mequon 53092 18557743863 Adviser data Tortoise Index Solutions, LLC. 6363 College Boulevard Suite 100A Overland Park 66211 18448746339 Adviser data Tortoise Capital Advisors, LLC 6363 College Boulevard Suite 100A Overland Park 66211 18558223863 Adviser data Vident Investment Advisory, LLC. 89 Headquarters Plaza North Tower, 14th Floor Morristown 07960 19739153170 Adviser data Ecofin Advisors Limited 15 Buckingham Street Charing Cross London GB WC2N 6DU 4402074512941 Adviser data V-Square Quantitative Management 875 North Michigan Avenue Unit 3216 Chicago 60611 18448746339 Adviser data N N N N-1A 37 Y David Swanson N/A N David Massart 002332208 N Leonard Rush 000726159 N Robert Kern N/A N Deborah Ward N/A 615 E. Michigan Street Milwaukee 53202 XXXXXX N N N N N Quasar Distributors, LLC 8-52323 000103848 N/A N Compass Distributors, LLC 8-69518 000172662 N/A N Foreside Fund Services, LLC 8-51293 000046106 N/A N N Cohen & Company, Ltd. 00925 N/A Ernst & Young LLP 00042 N/A N N N N N N Coho Relative Value Equity Fund S000041846 549300R5XY36KH8ZOP94 N 1 0 0 N/A N N Y N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Y N N Y Coho Partners Ltd. 801-60111 000111335 N/A N U.S. Bancorp Fund Services, LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services, LLC N1GZ7BBF3NP8GI976H15 N/A N N N Wachovia Bank N.A. 8-65876 000126292 VYVVCKR63DVZZN70PB21 28556.000000000000 J.P. Morgan Chase 8-35008 000000079 ZBUT11V806EZRVTWT807 28015.000000000000 Credit Suisse 8-42200 000000816 1V8Y6QCX6YMJ2OELII46 21662.000000000000 Barclay Investments, Ltd. 8-41342 000019714 AC28XWWI3WIBK2824319 16638.000000000000 Raymond James & Associates, Inc. 8-10999 000000705 U4ONQX15J3RO8XCKE979 15924.000000000000 Sanford C. Bernstein & Co. LLC 8-52942 000104474 549300I7JYZHT7D5CO04 14941.000000000000 Morgan Stanley & Co., Inc. 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 14158.000000000000 Merrill Lynch, Inc. 8-33359 000016139 549300PMHS66E71I2D34 11321.000000000000 Jefferies & Company, Inc. 8-15074 000002347 58PU97L1C0WSRCWADL48 8582.000000000000 Jones & Associates, Inc. 8-26089 000006888 2138008JJ5PA8H5UIL69 4635.000000000000 164433.000000000000 0.000000000000 Y 960724237.760000000000 Committed 50000000.000000000000 N N N N Coho Relative Value ESG Fund S000067007 5493009X0E8H4K7BYT91 N 1 0 0 N/A N N Y N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Y Y Y N Coho Partners Ltd. 801-60111 000111335 N/A N U.S. Bancorp Fund Services, LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services, LLC N1GZ7BBF3NP8GI976H15 N/A N N N Credit Suisse 8-42200 000000816 1V8Y6QCX6YMJ2OELII46 2940.000000000000 Raymond James & Associates, Inc. 8-10999 000000705 U4ONQX15J3RO8XCKE979 2499.000000000000 J.P. Morgan Chase 8-35008 000000079 ZBUT11V806EZRVTWT807 1599.000000000000 Wachovia Bank N.A. 8-65876 000126292 VYVVCKR63DVZZN70PB21 1096.000000000000 Barclay Investments, Ltd. 8-41342 000019714 AC28XWWI3WIBK2824319 1034.000000000000 Sanford C. Bernstein & Co. LLC 8-52942 000104474 549300I7JYZHT7D5CO04 656.000000000000 Merrill Lynch, Inc. 8-33359 000016139 549300PMHS66E71I2D34 516.000000000000 Morgan Stanley & Co., Inc. 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 397.000000000000 Jones & Associates, Inc. 8-26089 000006888 2138008JJ5PA8H5UIL69 161.000000000000 Jefferies & Company, Inc. 8-15074 000002347 58PU97L1C0WSRCWADL48 17.000000000000 10915.000000000000 0.000000000000 Y 35605878.530000000000 N N N N true INTERNAL CONTROL RPT 2 g1aiii_1.htm INTERNAL CONTROL LETTER

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders of Coho Funds and
Board of Trustees of Managed Portfolio Series

In planning and performing our audit of the financial statements of Coho Relative Value Equity Fund and Coho Relative Value ESG Fund (the “Coho Funds” or “Funds”), each a series of Managed Portfolio Series, as of and for the year ended July 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds’ internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting.  Accordingly, we express no such opinion.

The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Funds’ annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Funds’ internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Funds’ internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of July 31, 2022.

This report is intended solely for the information and use of management and the Board of Trustees of the Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.


/s/ COHEN & COMPANY, LTD.

COHEN & COMPANY, LTD.
Milwaukee, Wisconsin
September 28, 2022